JIANGSU HENGRUI MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.61 CNY | +2.96% |
|
+9.43% | +0.84% |
| Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
| Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.18% | 2 M€ | -16.59% | - | |
| 3.73% | 2 M€ | -14.14% | ||
| 1.74% | 1 M€ | -9.86% | - | |
| 1.18% | 96 M€ | -1.45% | ||
| 0.51% | 35 M€ | -5.85% | - | |
| 0.27% | 4 M€ | -11.56% | ||
| 0.15% | 11 M€ | +1.79% | ||
| 0.07% | 1 M€ | +3.49% | - | |
| 0.07% | 3 M€ | -.--% | - | |
| 0.03% | 441 M€ | +4.60% | - | |
| 0.03% | 2,808 M€ | +5.90% | - | |
| 0.03% | 149 M€ | +2.17% | - | |
| 0.03% | 117 M€ | +1.11% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.01% | 31 M€ | +3.50% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - |
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products:
- anti-tumor drugs (No. 1 Chinese);
- Anesthetic drugs;
- contrast agents: used in medical imaging;
- anti-inflammatory drugs;
- drugs for the treatment of cardiovascular diseases.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
45.61
CNY
Average target price
57.6
CNY
Spread / Average Target
+26.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.84% | 40.02B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.
